SkinHealth Systems Inc.

Good afternoon and welcome to the Beauty Health Company third quarter 2023 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. Please note, this event is being recorded. I would like now to turn the conference over to Norberto Aja, Investor Relations. Please go ahead.

Thank you, operator, and good afternoon, everyone. Thank you for joining us today to discuss the Beauty Health Company's third quarter 2023 financial results, which we released this afternoon and can be found on our website at beautyhealth.com. With me today are Beauty Health's board member and incoming interim chief executive officer, Marla Beck, and our chief financial officer, Mike Monahan. Today's call will not include a Q&A session. though management will be available afterwards for any follow-up questions you may have. Before we begin, I would like to remind you of the company's safe harbor language. Management may make forward-looking statements including guidance and underlying assumptions, forward-looking statements that are based on expectations that involve risk and uncertainties that could cause actual results to defer materially. Listeners are cautioned not to place undue reliance on any forward-looking statements. For further discussion of risks related to our business, please see our filings with the SEC. This call will present non-GAAP financial measures. A reconciliation of these non-GAAP measures to the most comparable GAAP measures can be found in our earnings press release filed with the SEC today and available on our website. With that, I would now like to turn the call over to Marla. Please go ahead.

Thank you, Norberto, and thank you everyone for joining us on the call today. Before I start, on behalf of the board, I would like to thank Andrew for his leadership and commitment to beauty health. I look forward to partnering closely with him during this transition period. I'm excited to join beauty health as the interim CEO. For those of you who do not know me, I've spent my entire career in the beauty and wellness space. notably as CEO of Blue Mercury for 22 years. I founded Blue Mercury in 1999 and built the company from zero to a strategic sale to Macy's in 2015, after which I ran Blue Mercury as a division of Macy's for six years under both Terry Lundgren and Jeff Gannett. My focus has always been on building high growth, profitable, enduring companies with an acute focus on the customer, high-performing teams, and operational excellence. I look forward to bringing this skill set to Beauty Health and working with the team to drive revenue, profit, and build an enduring company while delivering long-term value to our shareholders. I'm confident my experience will serve Beauty Health well in addressing current challenges while delivering on the many opportunities ahead of us. Since joining the board, it has become evident that Hydrofacial's ability to engage and attract consumers is differentiated within the aesthetics place, where consumers are more likely to know about generic treatments like fillers or laser rather than a specific treatment brand name. Regularly, providers report that their decision to buy a device is in part because their clients ask for a Hydrofacial treatment by name. This represents a significant competitive advantage for beauty health. My focus is to protect Hydrofacial's incredible brand equity and to address provider experience challenges with Sundeo, Hydrofacial's newest generation delivery system. While we can all acknowledge that many mistakes were made with regard to Sundeo, we always put our customers first. As a result, we are taking some tough actions this quarter to do the right thing. Once we work through these, we can again go back to empowering the team to continue to drive our revenue and capitalize on our substantial growth opportunities. I am a believer in beauty health's current strategy to capitalize on the blue sky potential in front of us and welcome the opportunity to execute on our vision. With that, I will turn the call over to Mike to discuss the quarter's performance.